E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 12/9/2005 in the Prospect News PIPE Daily.

New Issue: MedAvant discloses details of $20 million private placement

By Sheri Kasprzak

New York, Dec. 9 - MedAvant Inc. released details of its $20 million private placement with Laurus Master Fund, Ltd.

MedAvant received a $5 million secured term loan and a $15 million secured revolving credit facility.

The term loan matures in five years and bears interest at Prime rate plus 200 basis points with an 8% floor. The loan is payable in equal monthly installments with the last payment due on Dec. 6, 2010.

The revolver matures on Dec. 6, 2008 and bears interest at Libor plus 500 basis points with a 7% floor.

Laurus received 500,000 shares as part of the loan agreement.

Proceeds will be used to repay senior debt to Wachovia Bank, National Corp. The rest will be used for working capital.

Atlanta-based MedAvant is a health care technology services company focused on health care transaction processing, medical cost containment services, business process outsourcing and other services to physicians and pharmacists.

Term loan

Issuer:MedAvant Inc.
Issue:Secured term loan
Amount:$5 million
Maturity:Dec. 6, 2010
Coupon:Prime rate plus 200 basis points, 8% floor
Shares:500,000
Warrants:No
Investor:Laurus Master Fund, Ltd.
Settlement date:Dec. 7
Stock price:$4.74 at close Dec. 7
Revolver
Issuer:MedAvant Inc.
Issue:Secured revolving credit facility
Amount:$15 million
Maturity:Dec. 6, 2008
Coupon:Libor plus 500 basis points, 7% floor
Warrants:No
Investor:Laurus Master Fund, Ltd.
Settlement date:Dec. 7
Stock price:$4.74 at close Dec. 7

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.